SNMMI: Education eases patients' nuclear medicine fears
June 15, 2017 -- DENVER - By providing basic educational materials on nuclear medicine and the potential risks from radiation exposure, clinicians can make patients feel more comfortable about their upcoming scans, according to a presentation on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.
SNMMI Image of the Year awarded to German researchers
June 14, 2017 -- DENVER - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) on Wednesday awarded its Image of the Year to researchers who used PET/CT followed by fluorescence-guided surgery to demonstrate how dual-labeled prostate-specific membrane antigen (PSMA) inhibitors based on PSMA-11 enhance preoperative staging of metastatic prostate cancer.
SNMMI: PET/ultrasound targets recurrent prostate cancer
June 14, 2017 -- DENVER - Researchers at Emory University are reporting early success in fusing fluciclovine-PET and 3D ultrasound images to better detect and biopsy suspected recurrent prostate cancer. They presented their findings at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.
SNMMI: SPECT shows brain changes in football players
June 13, 2017 -- DENVER - SPECT scans show changes in cerebral blood flow in retired professional football players that differ based on which position they played, according to researchers from the University of California, Los Angeles. The findings were presented on Monday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.
High amyloid levels on PET may indicate early Alzheimer's
June 13, 2017 -- Elevated levels of amyloid on PET scans of the brain have been associated with an increased risk for Alzheimer's disease. But a study published June 13 in the Journal of the American Medical Association suggests that higher levels of amyloid could actually be the first preclinical sign of the illness.
SNMMI: FET-PET could have answers for brainstem glioma
June 12, 2017 -- DENVER - Researchers in Switzerland are setting their sights on fluoroethyl-tyrosine (FET) PET imaging as the best way to assess adult brainstem glioma and gauge patients' chances for progression-free survival. Study results were presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
CZT-based SPECT MPI may predict cardiac outcomes
May 9, 2017 -- SPECT gamma cameras featuring cadmium zinc telluride-based (CZT) digital detector technology are just what the nuclear cardiologist ordered to diagnose seemingly healthy patients with cardiac symptoms and to help predict their chances for an adverse event, according to a study published online April 27 in the Journal of Nuclear Medicine.
Nuclear cardiology lab cuts radiation dose by 60%
May 8, 2017 -- A large nuclear cardiology lab was able to reduce its average radiation dose by 60% over the past eight years, according to new research presented on Friday at the International Conference on Nuclear Cardiology and Cardiac CT in Vienna and published in JACC: Cardiovascular Imaging.
SPECT/CT can solve renal cell carcinoma diagnosis conundrum
April 27, 2017 -- By turning to a SPECT/CT scan with technetium-99m sestamibi, clinicians can overcome inconclusive or suspicious CT or MRI results and are better able to characterize and diagnose renal cell carcinoma, according to a study published in the April issue of Clinical Nuclear Medicine.
PET plays key role in preventive Alzheimer's study
April 19, 2017 -- With projections that the number of people living with Alzheimer's disease in the U.S. could more than triple by the year 2050, 65 research institutions are collaborating on a clinical trial using PET scans to identify the disease in its earliest stages, as well as guide the use of potential therapeutic agents.